Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations

Highly specialised technologies guidance
Reference number: HST11
Published: 09 October 2019

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 149 KB)

Published:

09 October 2019

Final evaluation determination

Final evaluation determination
Final evaluation determination document (PDF 370 KB)

Published:

04 September 2019
Public committee slides (PDF 2.04 MB)

Published:

04 September 2019
Committee papers (PDF 7 MB)

Published:

04 September 2019

Invitation to participate

Final stakeholder list (PDF 219 KB)

Published:

03 December 2018
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 776 KB)

Published:

03 December 2018
Final scope (PDF 258 KB)

Published:

03 December 2018
Equality Impact Assessment (Guidance development) (PDF 176 KB)

Published:

03 December 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 344 KB)

Published:

26 July 2017
Draft matrix pre referral (PDF 218 KB)

Published:

26 July 2017